Phase II Study of Antineoplaston A10 and AS2-1 in Children with Recurrent and Progressive Multicentric Glioma: A Preliminary Report

By Stanislaw R. Burzynski  

Drugs in R&D, Vol. 5, Iss. 6, 2004-01 ,pp. : 315-326

Adis International

Access to resources Recommend Favorite

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial

By Galanis Evanthia   Buckner Jan   Maurer Matthew   Reid Joel   Kuffel Mary   Ames Matthew   Scheithauer Bernd   Hammack Julie   Pipoly George   Kuross Steven  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 495-503

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

By Chang Susan   Wen Patrick   Cloughesy Timothy   Greenberg Harry   Schiff David   Conrad Charles   Fink Karen   Robins H.   Angelis Lisa   Raizer Jeffrey   Hess Kenneth   Aldape Ken   Lamborn Kathleen   Kuhn John   Dancey Janet   Prados Michael  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 357-361

Springer Publishing Company

Access to resources Recommend Favorite

Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma

By  

Current Neuropharmacology, Vol. 15, Iss. 1, 2016-12 ,pp. : 104-115

Bentham Science Publishers

Access to resources Recommend Favorite

Survival of Patients with Recurrent Malignant Glioma Treated with Temozolomide: A Retrospective Observational Study

By Trippoli S.   Pelagotti F.   Messori A.   Vacca F.   Vaiani M.   Maltoni S.  

Drugs in R&D, Vol. 4, Iss. 5, 2003-01 ,pp. : 285-291

Adis International

Access to resources Recommend Favorite